A 48-year-old man in Winnipeg who says his right leg was to be amputated due to an infection came out of the medical ...

Canadian clinical trial company Arch Biopartners has dosed the first patient in Canada in its Phase II clinical trial of ...

Belite Bio, Inc. ( NASDAQ: BLTE) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Tom Lin - Chairman and Chief Executive Officer Hendrik Scholl - Chief Medical Officer Nathan Mata - Chief ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

The US Food and Drug Administration (FDA) has awarded the second breakthrough therapy designation (BTD) to Johnson & ...

Police say 23 people are in custody after at least 100 shots were fired in an exchange of gunfire outside a West Queen West ...

And for the first half of 2024, we have seen a slight increase in pricing with stable market share. Also interesting to note is the U.S. patient pool continues to ... no trends observed in adverse ...

In August 2024, Artiva announced the treatment of its first patient was initiated in an investigator-initiated basket trial (IIT) assessing the safety, tolerability, and clinical activity of AlloNK ® ...

The B.C. Conservation Officer Service is warning Whistler residents and visitors not to feed or approach black bears after a ...

Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...